The Pharmaceutical Industry

[jinx]

FDA: Indian drug co lied about test results for generic drugs. (also CNN)

Ranbaxy Laboratories Limited Inc., the firm which has helped propel India into a major player in the global pharmaceutical market, did not properly test the shelf-life of about 25 generic drugs then lied about how they conducted the tests and falsified results to cover up testing irregularities, the FDA said.

FDA officials said no harm to patients who took the dozens of Ranbaxy drugs has been detected, there is no evidence that the drugs are dangerous, and no recall of the drugs is necessary. Officials said patients prescribed Ranbaxy drugs should continue to take their medications. All 25 generic drugs made at the Ranbaxy plant now under investigation likely made their way into the U.S., the FDA said.